Pfizer Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 48,418.0 | 48,371.0 | 51,298.0 |
| Cost of Goods Sold | 11,239.0 | 7,640.0 | 8,525.0 |
| Gross Profit | 37,179.0 | 40,731.0 | 42,773.0 |
| Gross Profit Margin | 76.8% | 84.2% | 83.4% |
| SG&A Expense | 24,460.0 | 23,314.0 | 25,316.0 |
| Depreciation & Amortization | 5,200.0 | 5,293.0 | 5,576.0 |
| Operating Income | 7,519.0 | 12,124.0 | 11,881.0 |
| Operating Margin | 15.5% | 25.1% | 23.2% |
| Nonoperating Income | 2,156.0 | 1,392.0 | 124.0 |
| Nonoperating Expenses | 397.0 | 488.0 | 471.0 |
| Income Before Taxes | 9,278.0 | 13,028.0 | 11,534.0 |
| Income Taxes | 1,023.0 | 1,992.0 | 3,424.0 |
| Net Income After Taxes | 8,255.0 | 11,036.0 | 8,110.0 |
| Continuing Operations | 8,213.0 | 11,024.0 | 8,094.0 |
| Discontinued Operations | (69.0) | 8,313.0 | 16.0 |
| Total Operations | 8,144.0 | 19,337.0 | 8,110.0 |
| Total Net Income | 8,144.0 | 19,337.0 | 8,085.0 |
| Net Profit Margin | 16.8% | 40.0% | 15.8% |
| Diluted EPS from Total Net Income ($) | 1.17 | 2.66 | 1.09 |
| Dividends per Share | 1.16 | 1.20 | 0.76 |




